July 18, 2012, Vol 308, No. 3, Pages 211-305

This Week in JAMA

Abstract Full Text

free access has audio

JAMA. 2012;308(3):211. doi:10.1001/jama.2012.3108

Audio Editors' Summary: JAMA: 2012-07-18, Vol. 308, No. 3, Editor's Audio Summary

Viewpoint

ONLINE FIRST

Marshaling Leadership for High-Value Health Care: An Institute of Medicine Discussion Paper

Patricia Gabow, MD; George Halvorson; Gary Kaplan, MD

Abstract Full Text

has audio

JAMA. 2012;308(3):239-240. doi:10.1001/jama.2012.7081

Audio Author Interview: Marshaling Leadership for High-Value Health Care

Is It Time to Replace the Tuberculin Skin Test With a Blood Test?

Philip A. LoBue, MD; Kenneth G. Castro, MD

Abstract Full Text

JAMA. 2012;308(3):241-242. doi:10.1001/jama.2012.7511

Understanding Health Care as a Complex System: The Foundation for Unintended Consequences

Lewis A. Lipsitz, MD

Abstract Full Text

JAMA. 2012;308(3):243-244. doi:10.1001/jama.2012.7551

A Piece of My Mind

Making It From Home to First

Lawrence J. Hergott, MD

Abstract Full Text

JAMA. 2012;308(3):245-246. doi:10.1001/jama.2012.7816

Original Contribution

Association Between Use of Interferon Beta and Progression of Disability in Patients With Relapsing-Remitting Multiple Sclerosis

Afsaneh Shirani, MD; Yinshan Zhao, PhD; Mohammad Ehsanul Karim, MSc; et al.

Abstract Full Text

free access has multimedia has audio

JAMA. 2012;308(3):247-256. doi:10.1001/jama.2012.7625

Shirani and coauthors analyzed data from 2656 patients with relapsing-remitting multiple sclerosis in British Columbia from 1985 to 2008 to investigate whether treatment with interferon beta was associated with a reduction in disability progression. In an ⁸³²⁷, Derfuss and Kappos discuss interferon’s potential benefits in MS.

Audio Author Interview: Association Between Use of Interferon Beta and Progression of Disability in Patients With Relapsing-Remitting Multiple Sclerosis

Editorial
Evaluating the Potential Benefit of Interferon Treatment in Multiple Sclerosis
Tobias Derfuss, MD; Ludwig Kappos, MD

JAMA

Comparison of 30-Day Mortality Models for Profiling Hospital Performance in Acute Ischemic Stroke With vs Without Adjustment for Stroke Severity

Gregg C. Fonarow, MD; Wenqin Pan, PhD; Jeffrey L. Saver, MD; et al.

Abstract Full Text

free access

JAMA. 2012;308(3):257-264. doi:10.1001/jama.2012.7870

Fonarow and coauthors used data on 127 950 Medicare beneficiaries with acute ischemic stroke to evaluate how hospital outcome ratings are altered after including initial stroke severity in claims-based hospital mortality risk models. In an ⁸⁴⁴⁸, Kurth and Elkind discuss the importance of incorporating stroke severity when conducting health outcomes research in stroke.

Editorial
Comparing Hospitals on Stroke Care: The Need to Account for Stroke Severity
Tobias Kurth, MD, ScD; Mitchell S. V. Elkind, MD, MS

JAMA

Variation in Patient-Sharing Networks of Physicians Across the United States

Bruce E. Landon, MD, MBA; Nancy L. Keating, MD, MPH; Michael L. Barnett, MD; et al.

Abstract Full Text

free access has multimedia

JAMA. 2012;308(3):265-273. doi:10.1001/jama.2012.7615

Dr Landon and coauthors report on variations in patient-sharing networks of physicians across the United States. In an accompanying ⁷⁴⁷⁶, Drs Lewis and Fisher discuss social networks in health care.

Editorial
Social Networks in Health Care: So Much to Learn
Valerie A. Lewis, PhD; Elliott S. Fisher, MD, MPH

JAMA

Effect of Silymarin (Milk Thistle) on Liver Disease in Patients With Chronic Hepatitis C Unsuccessfully Treated With Interferon Therapy: A Randomized Controlled Trial

Michael W. Fried, MD; Victor J. Navarro, MD; Nezam Afdhal, MD; et al.

Abstract Full Text

free access

JAMA. 2012;308(3):274-282. doi:10.1001/jama.2012.8265

To determine the effect of silymarin on liver disease activity in patients with chronic hepatitis C virus (HCV) infection unsuccessfully treated with interferon-based therapy, Fried and coauthors randomly assigned 154 such patients to receive 420-mg silymarin, 700-mg silymarin, or matching placebo.

Editorial

Evaluating the Potential Benefit of Interferon Treatment in Multiple Sclerosis

Tobias Derfuss, MD; Ludwig Kappos, MD

Abstract Full Text

JAMA. 2012;308(3):290-291. doi:10.1001/jama.2012.8327

Comparing Hospitals on Stroke Care: The Need to Account for Stroke Severity

Tobias Kurth, MD, ScD; Mitchell S. V. Elkind, MD, MS

Abstract Full Text

JAMA. 2012;308(3):292-294. doi:10.1001/jama.2012.8448

Social Networks in Health Care: So Much to Learn

Valerie A. Lewis, PhD; Elliott S. Fisher, MD, MPH

Abstract Full Text

JAMA. 2012;308(3):294-296. doi:10.1001/jama.2012.7476

Grand Rounds

Current Approaches to Tuberculosis in the United States

Fred M. Gordin, MD; Henry Masur, MD

Abstract Full Text

JAMA. 2012;308(3):283-289. doi:10.1001/jama.2012.7505

Gordin and Masur discuss the resurgence in developing new tools and approaches in public health infrastructure of tuberculosis in the United States. See the related ⁷⁵¹¹ by LoBue and Castro.

Medical News & Perspectives

Chronic Mental Health Issues in Children Now Loom Larger Than Physical Problems

Anita Slomski

Abstract Full Text

JAMA. 2012;308(3):223-225. doi:10.1001/jama.2012.6951

USPSTF: Taking Vitamin D and Calcium Doesn’t Prevent Fractures in Older Women

Bridget M. Kuehn

Abstract Full Text

JAMA. 2012;308(3):225-226. doi:10.1001/jama.2012.7955

Families Still Let Guard Down With Allergic Children

Rebecca Voelker

Abstract Full Text

JAMA. 2012;308(3):226. doi:10.1001/jama.2012.8476

News From the Centers for Disease Control and Prevention

Prevalence of Stroke—United States, 2006–2010

Abstract Full Text

free access

JAMA. 2012;308(3):228-230. doi:

Exposure to Nitrogen Dioxide in an Indoor Ice Arena—New Hampshire, 2011

Abstract Full Text

free access

JAMA. 2012;308(3):230-232. doi:

Global Health

Afghan Mental Health Services

M. J. Friedrich

Abstract Full Text

JAMA. 2012;308(3):227. doi:10.1001/jama.2012.7729

Better Dementia Assessments

M. J. Friedrich

Abstract Full Text

JAMA. 2012;308(3):227. doi:10.1001/jama.2012.8388

Smoke and Developing Brains

M. J. Friedrich

Abstract Full Text

JAMA. 2012;308(3):227. doi:10.1001/jama.2012.8389

Anti–HIV-1 Antibodies

M. J. Friedrich

Abstract Full Text

JAMA. 2012;308(3):227. doi:10.1001/jama.2012.8390

Letters

Retinal Detachment and Fluoroquinolones

Petros Aristodemou, FRCOphth(Lond); Andreas C. Stylianides, MD, FRCP(Lond)

Abstract Full Text

JAMA. 2012;308(3):233. doi:10.1001/jama.2012.6618

Retinal Detachment and Fluoroquinolones

Aoife C. Molloy, MD, DTMH, MRCPUK; Danny Mitry, MD, MRCSI(Ophth)

Abstract Full Text

JAMA. 2012;308(3):233. doi:10.1001/jama.2012.6620

Retinal Detachment and Fluoroquinolones

Rajesh C. Rao, MD; Brian J. Dlouhy, MD

Abstract Full Text

JAMA. 2012;308(3):233. doi:10.1001/jama.2012.6628

Retinal Detachment and Fluoroquinolones

Mohammad H. Nowroozzadeh, MD

Abstract Full Text

JAMA. 2012;308(3):233. doi:10.1001/jama.2012.6630

Retinal Detachment and Fluoroquinolones—Reply

Mahyar Etminan, PharmD, MSc; James M. Brophy, MD, PhD; David Maberley, MD, MSc

Abstract Full Text

JAMA. 2012;308(3):233. doi:10.1001/jama.2012.6634

Supplementary Imaging for Breast Cancer Screening in High-Risk Women

Tetsuji Fujita, MD

Abstract Full Text

JAMA. 2012;308(3):236. doi:10.1001/jama.2012.7545

Supplementary Imaging for Breast Cancer Screening in High-Risk Women

Steven A. Narod, MD

Abstract Full Text

JAMA. 2012;308(3):236. doi:10.1001/jama.2012.7547

Supplementary Imaging for Breast Cancer Screening in High-Risk Women—Reply

Wendie A. Berg, MD, PhD; Richard G. Barr, MD, PhD; Zheng Zhang, PhD

Abstract Full Text

JAMA. 2012;308(3):236. doi:10.1001/jama.2012.7549

Medication Discount Program

Charles E. Hart, MD, MS; Bruce Siegel, MD, MPH

Abstract Full Text

JAMA. 2012;308(3):237-238. doi:10.1001/jama.2012.6622

Medication Discount Program—Reply

Mike Mitka

Abstract Full Text

JAMA. 2012;308(3):237-238. doi:10.1001/jama.2012.6624

The Cover

Self-portrait

Thomas B. Cole, MD, MPH

Abstract Full Text

JAMA. 2012;308(3):218. doi:10.1001/jama.2012.3104

Poetry and Medicine

Night View, Pediatric Oncology

Ronald Pies, MD

Abstract Full Text

JAMA. 2012;308(3):219. doi:10.1001/jama.2012.3627

JAMA Patient Page

Innocent (Harmless) Heart Murmurs in Children

Ann R. Punnoose, MD; Alison E. Burke, MA; Robert M. Golub, MD

Abstract Full Text

free access

JAMA. 2012;308(3):305. doi:10.1001/jama.2012.6223

Correction

Incorrect Author Name in Reference in: Designing Health Care for the Most Common Chronic Condition—Multimorbidity

Abstract Full Text

free access

JAMA. 2012;308(3):238. doi:10.1001/jama.2012.7465

JAMA 100 Years Ago

Book and Media Reviews

Hadzic’s Peripheral Nerve Blocks and Anatomy for Ultrasound-Guided Regional Anesthesia

Anthony Edelman, MD

Abstract Full Text

JAMA. 2012;308(3):297. doi:10.1001/jama.308.3.297-a

Atlas of Emergency Ultrasound

Christopher L. Moore, MD, RDMS, RDCS

Abstract Full Text

JAMA. 2012;308(3):297-298. doi:10.1001/jama.308.3.297-b

September 2023 - July 1883

Decade

Year

Issue

July 18, 2012, Vol 308, No. 3, Pages 211-305

ONLINE FIRST

Latest from the USPSTF